High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
![Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml](https://www.docpeter.it/media/catalog/product/p/r/prontinal_800_mcg_sospensione_per_nebulizzatore_0_8_mg_2_ml_sospensione_da_n_032798023.jpg)
Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml
Package leaflet: Information for the patient <Invented name> 400 micrograms Nebuliser Suspension <Invented name> 800
![A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e94385f0-8043-48e8-b744-a3c1441be519/gr2_lrg.jpg)
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory
RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 1. DENOMINAZIONE DEL MEDICINALE Beclometasone Teva 400 microgrammi sospensione per
![Notice patient - BECLOMETASONE TEVA 800 microgrammes/2 ml, suspension pour inhalation par nébuliseur en récipient unidose - Base de données publique des médicaments Notice patient - BECLOMETASONE TEVA 800 microgrammes/2 ml, suspension pour inhalation par nébuliseur en récipient unidose - Base de données publique des médicaments](http://prod-bdm.ansm.integra.fr/Rcp_Notices/images//N0371171/image009.gif)
Notice patient - BECLOMETASONE TEVA 800 microgrammes/2 ml, suspension pour inhalation par nébuliseur en récipient unidose - Base de données publique des médicaments
Foglio illustrativo: informazioni per l'utilizzatore Beclometasone Teva 400 microgrammi Sospensione per nebulizzatore Beclomet
![PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids](https://i1.rgstatic.net/publication/311554036_High_strength_extrafine_pMDI_beclometasoneformoterol_2006_mg_is_effective_in_asthma_patients_not_adequately_controlled_on_medium-high_dose_of_inhaled_corticosteroids/links/584c03e808aeb989251f23d6/largepreview.png)
PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids
![Budesonide teva sospensione per nebulizzatore - 0,5 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml Budesonide teva sospensione per nebulizzatore - 0,5 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml](https://www.docpeter.it/media/catalog/product/b/u/budesonide_teva_sospensione_per_nebulizzatore_0_5_mg_2_ml_sospensione_da_neb_035586015.png)
Budesonide teva sospensione per nebulizzatore - 0,5 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml
![PDF) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone PDF) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone](https://i1.rgstatic.net/publication/358598316_Interclass_Difference_in_Pneumonia_Risk_in_COPD_Patients_Initiating_Fixed_Dose_Inhaled_Treatment_Containing_Extrafine_Particle_Beclometasone_versus_Fine_Particle_Fluticasone/links/620cb968c5934228f96f7c0d/largepreview.png)